Skip to content
OpenCapital
Get started

Medtronic MDT Cardiovascular — Reportable segment operating profit

Other segment segments

Neuroscience
$879M+2.4%
Medical Surgical
$605M+5.2%
Diabetes
$57M+14.0%
Other operating segment
-$1M-108%

Similar metrics at other companies

Boston Scientific logo
BSXCardiovascular — Operating Income (Loss), Adjusted
$1.13B+5.3%
Boston Scientific logo
BSXCardiovascular — Segment operating income, percentage of net sale
32.1%-1.7pp
Boston Scientific logo
BSXCardiovascular — Net sales of reportable segments
$3.5B+10.9%
Boston Scientific logo
BSXCardiovascular — Cost of products sold, percentage of net sale
30.5%+1.2pp
Boston Scientific logo
BSXCardiovascular — Other segment items, percentage of net sale
0.2%0.0pp
Boston Scientific logo
BSXCardiovascular — Cost of products sold
$1.07B+15.2%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$101.86B-3.8%
Enterprise value$129.12B-3.2%
P/E21.2×-1.5×
P/S2.8×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Medtronic’s 10-K, filed June 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's cardiovascular — reportable segment operating profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's cardiovascular — reportable segment operating profit?
Medtronic (MDT) reported cardiovascular — reportable segment operating profit of $1.07B in Q1 2026.
How has Medtronic's cardiovascular — reportable segment operating profit changed year-over-year?
Medtronic's cardiovascular — reportable segment operating profit increased by 11.8% year-over-year, from $955M to $1.07B.
What is the long-term trend for Medtronic's cardiovascular — reportable segment operating profit?
Over 5 years (2021 to 2026), Medtronic's cardiovascular — reportable segment operating profit has grown at a -0.9% compound annual growth rate (CAGR), from $3.85B to $3.67B.
What does cardiovascular — reportable segment operating profit mean?
The profit earned by the cardiovascular segment from its core business operations.
How do you interpret cardiovascular — reportable segment operating profit?
Higher profit indicates strong demand, effective pricing power, and efficient cost management within the cardiovascular portfolio.
How does cardiovascular — reportable segment operating profit compare across companies?
Comparable to segment operating income reported by major medical device competitors in the cardiovascular space.